Navigating Vaccine Approval Transparency

This chapter examines the FDA's recent authorization of new mRNA vaccines from Moderna and Pfizer, highlighting concerns over the clarity and transparency of the regulatory process. The discussion emphasizes the need for rigorous scientific scrutiny and accountability in public health decision-making amid ongoing debates surrounding vaccine approval protocols.